FDA Inspection
Laboratorios Grifols, S.A.Laboratorios Grifols, S.A. – FDA Inspection, Sep 20, 2019
Record Details
This FDA Inspection record concerns Laboratorios Grifols, S.A., with an inspection on September 20, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · 5fd9d8e6-cf28-4754-a9c4-71994302bd3b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1123400
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Laboratorios Grifols, S.A.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2026 | Not classified | Office of Inspections and Investigations | |
| July 26, 2024 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Laboratorios Grifols, S.A.
- FDA Inspection 1325702 - 2026-06-19
- FDA Inspection 1244733 - 2024-07-26
- FDA Inspection 1268869 - 2023-10-27
- FDA Inspection 1025750 - 2017-09-08
- FDA Inspection 931864 - 2015-05-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.